Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2024 Volume 27 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2024 Volume 27 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway

  • Authors:
    • Dexuan Li
    • Zhengliang Xu
    • Yashan Li
    • Yanmei Huang
    • Jiali Yin
    • Hongjuan Li
    • Beiji Zhang
  • View Affiliations / Copyright

    Affiliations: Clinical Laboratory, The Third People's Hospital of Yunnan Province, Kunming, Yunnan 650011, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 26
    |
    Published online on: November 22, 2023
       https://doi.org/10.3892/etm.2023.12314
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study investigated the therapeutic potential of breviscapine (Bre) in mitigating lead (Pb)‑induced myocardial injury through activation of the nuclear factor erythroid‑2 related factor 2 (Nrf2) pathway. Rat cardiomyocytes (H9C2 cells) were exposed to Pb to model Pb poisoning, and various parameters, including cell viability, apoptosis and reactive oxygen species (ROS) production, were assessed using Cell Counting Kit‑8, flow cytometry and 2',7'‑dichlorfluoresceindiacetate assays, respectively. Additionally, a rat model of Pb poisoning was established in which blood Pb levels were measured using a graphite furnace atomic absorption spectrophotometer, and alterations in myocardial tissue, oxidative stress markers, inflammatory indicators, protein expression related to apoptosis and the Nrf2 pathway were evaluated via histopathology, ELISA and western blotting. The results showed that Bre treatment enhanced cell viability, decreased apoptosis, and reduced ROS production in Pb‑exposed H9C2 cells. Moreover, Bre modulated oxidative stress markers and inflammatory factors while enhancing the expression of proteins in the Nrf2 pathway. In a rat model, Bre mitigated the lead‑induced increase in blood Pb levels and myocardial injury biomarkers, and reversed the downregulation of Nrf2 pathway proteins. In conclusion, the current findings suggested that Bre mitigates Pb‑induced myocardial injury by activating the Nrf2 signaling pathway, highlighting its potential as a therapeutic agent for protecting the heart from the harmful effects of Pb exposure. Further research is required to elucidate the exact mechanisms and explore the clinical applicability of Bre in mitigating Pb‑induced myocardial damage.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Hanna-Attisha M, Lanphear B and Landrigan P: Lead poisoning in the 21st century: The silent epidemic continues. Am J Public Health. 108(1430)2018.PubMed/NCBI View Article : Google Scholar

2 

Charkiewicz AE and Backstrand JR: Lead Toxicity and Pollution in Poland. Int J Environ Res Public Health. 17(4385)2020.PubMed/NCBI View Article : Google Scholar

3 

Balali-Mood M, Naseri K, Tahergorabi Z, Khazdair MR and Sadeghi M: Toxic mechanisms of five heavy metals: Mercury, lead, chromium, cadmium, and arsenic. Front Pharmacol. 12(643972)2021.PubMed/NCBI View Article : Google Scholar

4 

Babiker F, Al-Kouh A and Kilarkaje N: Lead exposure induces oxidative stress, apoptosis, and attenuates protection of cardiac myocytes against ischemia-reperfusion injury. Drug Chem Toxicol. 42:147–156. 2019.PubMed/NCBI View Article : Google Scholar

5 

Yang D, Li S, Gao L, Lv Z, Bing Q, Lv Q, Zheng X, Li R and Zhang Z: Dietary grape seed procyanidin extract protects against lead-induced heart injury in rats involving endoplasmic reticulum stress inhibition and AKT activation. J Nutr Biochem. 62:43–49. 2018.PubMed/NCBI View Article : Google Scholar

6 

Ferreira G, Santander A, Chavarría L, Cardozo R, Savio F, Sobrevia L and Nicolson GL: Functional consequences of lead and mercury exposomes in the heart. Mol Aspects Med. 87(101048)2022.PubMed/NCBI View Article : Google Scholar

7 

Gao J, Chen G, He H, Liu C, Xiong X, Li J and Wang J: Therapeutic effects of breviscapine in cardiovascular diseases: A review. Front Pharmacol. 8(289)2017.PubMed/NCBI View Article : Google Scholar

8 

Yan L, Huang H, Tang QZ, Zhu LH, Wang L, Liu C, Bian ZY and Li H: Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling. J Cell Biochem. 109:1158–1171. 2010.PubMed/NCBI View Article : Google Scholar

9 

Li MJ, Sun WS, Yuan Y, Zhang YK, Lu Q, Gao YZ, Ye T and Xing DM: Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity. Front Pharmacol. 13(930835)2022.PubMed/NCBI View Article : Google Scholar

10 

Chen ZQ, Zhou Y, Chen F, Huang JW, Zheng J, Li HL, Li T and Li L: Breviscapine pretreatment inhibits myocardial inflammation and apoptosis in rats after coronary microembolization by activating the PI3K/Akt/GSK-3β Signaling pathway. Drug Des Devel Ther. 15:843–855. 2021.PubMed/NCBI View Article : Google Scholar

11 

Wang M, Zhang WB, Zhu JH, Fu GS and Zhou BQ: Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin-induced diabetic rats. Acta Diabetol. 47 (Suppl 1):S209–S218. 2010.PubMed/NCBI View Article : Google Scholar

12 

Zhang M, Yu X, Li D, Ma N, Wei Z, Ci X and Zhang S: Nrf2 signaling pathway mediates the protective effects of daphnetin against D-Galactose induced-premature ovarian failure. Front Pharmacol. 13(810524)2022.PubMed/NCBI View Article : Google Scholar

13 

Latella G: Redox imbalance in intestinal fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 connection. Dig Dis Sci. 63:312–320. 2018.PubMed/NCBI View Article : Google Scholar

14 

Tonelli C, Chio IIC and Tuveson DA: Transcriptional regulation by Nrf2. Antioxid Redox Signal. 29:1727–1745. 2018.PubMed/NCBI View Article : Google Scholar

15 

Chen QM: Nrf2 for cardiac protection: Pharmacological options against oxidative stress. Trends Pharmacol Sci. 42:729–744. 2021.PubMed/NCBI View Article : Google Scholar

16 

Song Y, Sun H, Gao S, Tang K, Zhao Y, Xie G and Gao H: Saikosaponin a attenuates lead-induced kidney injury through activating Nrf2 signaling pathway. Comp Biochem Physiol C Toxicol Pharmacol. 242(108945)2021.PubMed/NCBI View Article : Google Scholar

17 

Chen F, Zhou CC, Yang Y, Liu JW and Yan CH: GM1 ameliorates lead-induced cognitive deficits and brain damage through activating the SIRT1/CREB/BDNF pathway in the developing male rat hippocampus. Biol Trace Elem Res. 190:425–436. 2019.PubMed/NCBI View Article : Google Scholar

18 

Ding S, Liu D, Wang L, Wang G and Zhu Y: Inhibiting MicroRNA-29a protects myocardial ischemia-reperfusion injury by targeting SIRT1 and suppressing oxidative stress and NLRP3-Mediated pyroptosis pathway. J Pharmacol Exp Ther. 372:128–135. 2020.PubMed/NCBI View Article : Google Scholar

19 

Zawadzki M, Poreba R and Gać P: Mechanisms and toxic effects of lead on the cardiovascular system. Med Pr. 57:543–549. 2006.PubMed/NCBI(In Polish).

20 

Yao L, Chen H, Wu Q and Xie K: Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy. Int J Mol Med. 44:1048–1062. 2019.PubMed/NCBI View Article : Google Scholar

21 

Vukojevic K, Carev D, Sapunar D, Petrovic D and Saraga-Babic M: Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia. J Mol Histol. 39:339–349. 2008.PubMed/NCBI View Article : Google Scholar

22 

Yuan Y, He P, Tang X, Li J and Mu J: Effect of breviscapine on proliferation and apoptosis of H9c2 cardiomyocytes and activation of ERK1/2 signaling pathway. J Pract Med. 36:1611–1615. 2020.(In Chinese).

23 

Afsar T, Razak S, Batoo KM and Khan MR: Acacia hydaspica R: Parker prevents doxorubicin-induced cardiac injury by attenuation of oxidative stress and structural Cardiomyocyte alterations in rats. BMC Complement Altern Med. 17(554)2017.PubMed/NCBI View Article : Google Scholar

24 

Wang J, Ji SY, Liu SZ, Jing R and Lou WJ: Cardioprotective effect of breviscapine: Inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury. Pharmazie. 70:593–597. 2015.PubMed/NCBI

25 

Hayden J and Bostick B: Western diet induced obesity increases oxidative stress in the heart by impairing the Nrf2 antioxidant response pathway. J Am Coll Cardiol. 73 (9 Suppl)(S896)2019.

26 

Prasai PK, Shrestha B, Orr AW and Pattillo CB: Decreases in GSH:GSSG activate vascular endothelial growth factor receptor 2 (VEGFR2) in human aortic endothelial cells. Redox Biol. 19:22–27. 2018.PubMed/NCBI View Article : Google Scholar

27 

Quintana-Cabrera R, Fernandez-Fernandez S, Bobo-Jimenez V, Escobar J, Sastre J, Almeida A and Bolaños JP: γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor. Nat Commun. 3(718)2012.PubMed/NCBI View Article : Google Scholar

28 

Giustarini D, Tsikas D, Colombo G, Milzani A, Dalle-Donne I, Fanti P and Rossi R: Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG) in biological samples: An elephant in the room. J Chromatogr B Analyt Technol Biomed Life Sci. 1019:21–28. 2016.PubMed/NCBI View Article : Google Scholar

29 

Jiang X, Xing X, Zhang Y, Zhang C, Wu Y, Chen Y, Meng R, Jia H, Cheng Y, Zhang Y and Su J: Lead exposure activates the Nrf2/Keap1 pathway, aggravates oxidative stress, and induces reproductive damage in female mice. Ecotoxicol Environ Saf. 207(111231)2021.PubMed/NCBI View Article : Google Scholar

30 

He H, Wang L, Qiao Y, Zhou Q, Li H, Chen S, Yin D, Huang Q and He M: Doxorubicin induces endotheliotoxicity and mitochondrial dysfunction via ROS/eNOS/NO pathway. Front Pharmacol. 10(1531)2020.PubMed/NCBI View Article : Google Scholar

31 

Qiao Y, Hu T, Yang B, Li H, Chen T, Yin D, He H and He M: Capsaicin alleviates the deteriorative mitochondrial function by upregulating 14-3-3η in anoxic or anoxic/reoxygenated cardiomyocytes. Oxid Med Cell Longev. 2020(1750289)2020.PubMed/NCBI View Article : Google Scholar

32 

Guo J, Pu Y, Zhong L, Wang K, Duan X and Chen D: Lead impaired immune function and tissue integrity in yellow catfish (Peltobargus fulvidraco) by mediating oxidative stress, inflammatory response and apoptosis. Ecotoxicol Environ Saf. 226(112857)2021.PubMed/NCBI View Article : Google Scholar

33 

Yu L, Li HX, Guo JY, Huang YQ, Wang H, Talukder M and Li JL: Di (2-ethyl hexyl) phthalate (DEHP)-induced spleen toxicity in quail (Coturnix japonica) via disturbing Nrf2-mediated defense response. Environ Pollut. 251:984–989. 2019.PubMed/NCBI View Article : Google Scholar

34 

Yang D, Lv Z, Zhang H, Liu B, Jiang H, Tan X, Lu J, Baiyun R and Zhang Z: Activation of the Nrf2 Signaling pathway involving KLF9 plays a critical role in allicin resisting against arsenic trioxide-induced hepatotoxicity in rats. Biol Trace Elem Res. 176:192–200. 2017.PubMed/NCBI View Article : Google Scholar

35 

Ursini F, Maiorino M and Forman HJ: Redox homeostasis: The Golden Mean of healthy living. Redox Biol. 8:205–215. 2016.PubMed/NCBI View Article : Google Scholar

36 

Li J, Zheng X, Ma X, Xu X, Du Y, Lv Q, Li X, Wu Y, Sun H, Yu L and Zhang Z: Melatonin protects against chromium(VI)-induced cardiac injury via activating the AMPK/Nrf2 pathway. J Inorg Biochem. 197(110698)2019.PubMed/NCBI View Article : Google Scholar

37 

Liu B, Jiang H, Lu J, Baiyun R, Li S, Lv Y, Li D, Wu H and Zhang Z: Grape seed procyanidin extract ameliorates lead-induced liver injury via miRNA153 and AKT/GSK-3β/Fyn-mediated Nrf2 activation. J Nutr Biochem. 52:115–123. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li D, Xu Z, Li Y, Huang Y, Yin J, Li H and Zhang B: Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway. Exp Ther Med 27: 26, 2024.
APA
Li, D., Xu, Z., Li, Y., Huang, Y., Yin, J., Li, H., & Zhang, B. (2024). Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway. Experimental and Therapeutic Medicine, 27, 26. https://doi.org/10.3892/etm.2023.12314
MLA
Li, D., Xu, Z., Li, Y., Huang, Y., Yin, J., Li, H., Zhang, B."Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway". Experimental and Therapeutic Medicine 27.1 (2024): 26.
Chicago
Li, D., Xu, Z., Li, Y., Huang, Y., Yin, J., Li, H., Zhang, B."Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway". Experimental and Therapeutic Medicine 27, no. 1 (2024): 26. https://doi.org/10.3892/etm.2023.12314
Copy and paste a formatted citation
x
Spandidos Publications style
Li D, Xu Z, Li Y, Huang Y, Yin J, Li H and Zhang B: Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway. Exp Ther Med 27: 26, 2024.
APA
Li, D., Xu, Z., Li, Y., Huang, Y., Yin, J., Li, H., & Zhang, B. (2024). Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway. Experimental and Therapeutic Medicine, 27, 26. https://doi.org/10.3892/etm.2023.12314
MLA
Li, D., Xu, Z., Li, Y., Huang, Y., Yin, J., Li, H., Zhang, B."Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway". Experimental and Therapeutic Medicine 27.1 (2024): 26.
Chicago
Li, D., Xu, Z., Li, Y., Huang, Y., Yin, J., Li, H., Zhang, B."Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway". Experimental and Therapeutic Medicine 27, no. 1 (2024): 26. https://doi.org/10.3892/etm.2023.12314
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team